In patients undergoing PCI, there were no significant differences between those receiving drug-eluting stents and those receiving bare-metal stents in the composite outcome of death from any cause and nonfatal spontaneous myocardial infarction. Rates of repeat revascularization were lower in the group receiving drug-eluting stents. (Funded by the Norwegian Research Council and others; NORSTENT ClinicalTrials.gov number, NCT00811772 .).

No abstract

No abstract

OLE JOHAN JAKOBSENOle Johan Jakobsen er overlege ved Sørlandet sykehus, Arendal. Ingen oppgitte interessekonflikter.

Purpose: Cardiac Resynchronization Therapy (CRT) is currently being targeted to moderately and severely symptomatic heart failure patients (NYHA Class Ill and IV), with systolic dysfunction (Ejection fraction <35%) and evidences of ventricular dyssynchrony (QRS > 130ms). Aim of the study was to assess the effects of CRT in mildly symptomatic patients (NYHA Class II) with respect to patients with standard indications.Methods: 1232 patients (684-9 years, 1010 male, 569 ischemic) were enrolled in the InSync/InSync ICD Italian Registries and followed for 164-14 months. At baseline, 235 patients were classified in NYHA Class II (654-10 years, 1.74-1.0 hospitalizations for heart failure in the 12 months preceding the implant with a mean number of 9.34-7.8 days of hospitalization), the remaining 997 were in NYItA Class llI or IV (684-9* years, 2.34-1.4" hospitalizations with 22.24-17.1" days of hospitalization). *p<0.001 versus NYHA Class II.